Could a simple blood test flag heart risk in rheumatoid arthritis?

NCT ID NCT07760662

Recruiting now Knowledge-focused Sponsor: University of La Laguna Source: ClinicalTrials.gov ↗

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This study looks at whether certain markers of oxidative stress in the blood are linked to early signs of heart disease in people with rheumatoid arthritis. Researchers will measure these markers and check for thickening or stiffness in the carotid arteries. The goal is to better understand the connection between inflammation, oxidative stress, and cardiovascular risk in this condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If oxidative stress markers are linked to early heart disease in rheumatoid arthritis, this could lead to better screening or new treatments to protect the heart.
What could go wrong: This is an observational study, so it cannot prove cause and effect. The findings may not apply to all patients with rheumatoid arthritis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR (CV) RISK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR (CV) RISK OXIDATIVE STRESS RHEUMATOID ARTHRITIS (RA)

Contacts and locations

Locations

Hospital Universitario de Canarias
RECRUITING

Santa Cruz de Tenerife, Canary Islands, 38320, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.